Sargramostim With Ipilimumab Containing Therapy in Patients With Solid Tumors

NCT05284214 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Study did not commence.

Conditions

Interventions

Sponsor

Partner Therapeutics, Inc.